These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5371784)

  • 41. Immunotherapy for parasitic disease.
    Neva FA
    N Engl J Med; 1990 Jan; 322(1):55-7. PubMed ID: 2104667
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India.
    Stauch A; Duerr HP; Dujardin JC; Vanaerschot M; Sundar S; Eichner M
    PLoS Negl Trop Dis; 2012; 6(12):e1973. PubMed ID: 23285309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [METABOLISM OF ANTIMONY IN CHILDREN WITH VISCERAL LEISHMANIASIS TREATED WITH SOLUSURMIN. II].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1964; 33():438-43. PubMed ID: 14250146
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of post-kala-azar dermal leishmaniasis.
    Singh S; Sundar S
    Int J Dermatol; 1995 Sep; 34(9):668-9. PubMed ID: 7591476
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of visceral leishmaniasis with solusurmin in children].
    KARAKHODZHAEV BKh
    Pediatriia; 1953; 4():60-1. PubMed ID: 13088230
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of infantile visceral leishmaniasis with solusurmin according to material of the parasitological department of the Tashkent City Sanitary-Epidemiological Station].
    MIKHAILOV VG; STARTSEVA MA
    Med Parazitol (Mosk); 1961; 30():563-7. PubMed ID: 14473694
    [No Abstract]   [Full Text] [Related]  

  • 47. Compassionate use of sitamaquine in an HIV-positive patient with visceral leishmaniasis.
    Rashid JR; Nyakundi PM; Kirigi G; Kinoti D; Wasunna MK
    Trans R Soc Trop Med Hyg; 2002; 96(5):533-4. PubMed ID: 12474482
    [No Abstract]   [Full Text] [Related]  

  • 48. Reply to Das.
    Dujardin JC; Bhattarai NR; Rai K; Vanaerschot M; Uranw S; Ostyn BA; Boelaert M; Rijal S
    Clin Infect Dis; 2013 Nov; 57(9):1365-6. PubMed ID: 23943823
    [No Abstract]   [Full Text] [Related]  

  • 49. Concerns about topical treatment for new world cutaneous leishmanisis.
    Monge-Maillo B; Pérez-Molina JA; Norman FF; López-Vélez R
    Clin Infect Dis; 2013 Nov; 57(10):1502-3. PubMed ID: 23946223
    [No Abstract]   [Full Text] [Related]  

  • 50. Reply to Monge-Maillo et al.
    Soto J; Berman J
    Clin Infect Dis; 2013 Nov; 57(10):1503-4. PubMed ID: 23946219
    [No Abstract]   [Full Text] [Related]  

  • 51. Reply to Arya and Agarwal.
    Dorlo TP; Ostyn BA; Beijnen JH; Boelaert M; Dujardin JC; Rijal S
    Clin Infect Dis; 2013 Sep; 57(6):917-8. PubMed ID: 23759350
    [No Abstract]   [Full Text] [Related]  

  • 52. Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline.
    Alving CR; Steck EA; Chapman WL; Waits VB; Hendricks LD; Swartz GM; Hanson WL
    Life Sci; 1980 Jun; 26(26):2231-8. PubMed ID: 7401920
    [No Abstract]   [Full Text] [Related]  

  • 53. More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects.
    Olliaro P; Vaillant MT; Sundar S; Balasegaram M
    PLoS Negl Trop Dis; 2012; 6(5):e1545. PubMed ID: 22666508
    [No Abstract]   [Full Text] [Related]  

  • 54. [What did prove useful in the treatment of leishmaniasis].
    Kurban A
    Hautarzt; 1973 Jun; 24(6):271. PubMed ID: 4723879
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of visceral leishmaniasis in patients with antimonials: is there a maximal dose?].
    Llorens Soriano P; Vicente Ull R; Paricio Blasco A; Cervera Juan A; Rubio Rodrigo MJ
    An Med Interna; 1999 Nov; 16(11):602. PubMed ID: 10638007
    [No Abstract]   [Full Text] [Related]  

  • 56. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 57. [Kala-azar in childhood].
    Ballin A; Theodor R; Boichis H; Rotem Y; Altman G
    Harefuah; 1980 Jun; 98(11-12):501-3. PubMed ID: 7203192
    [No Abstract]   [Full Text] [Related]  

  • 58. The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy.
    Hernández JA; Navarro JT; Force L
    Haematologica; 2001 Dec; 86(12):1319. PubMed ID: 11726328
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the treatment of visceral leishmaniasis in dogs with massive doses of solusurmin].
    Fuzailov IuM; Ibragimov II
    Med Parazitol (Mosk); 1969; 38(5):615-6. PubMed ID: 5371784
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.